The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
That's a great question 337. May be Snowking or Acker can answer it .
Given that the new EPO is 57 times the size of the previous epo what is the likely cost of running a full Dfs over the extended EPO area.
It sure as hell isn't going to be $5.1m.
I don't think these figures are very good. Name plate production is 800t per day and they are still a significant way off that in fact they seem to be regressing.
I can't see the update helping the share price
Good old Mr Thompson....